文献速递小儿神经外科与脑积水

PUMP研究:储液泵按压试验用于疑似引流不足的脑室腹腔分流术后正常压力脑积水患者

PUMP study: reservoir pumping in suspected underdrained shunted patients with normal pressure hydrocephalus - a prospective single-center study.
PubMed 文献 · Acta Neurochir (Wien) · 2025-12-22

这项前瞻性单中心研究纳入25例已行分流术且使用Sprung-Reservoir和proGAV 2.0阀门、疑似引流不足的正常压力脑积水患者,通过按压储液泵100次抽吸约20 ml脑脊液,评估10分钟后步态及一周内变化。结果显示该试验安全可行,76%(19例)避免了侵入性检查,可作为疑似引流不足时的一线无创诊断方法。

要点

  • 按压储液泵100次抽吸约20 ml脑脊液,10分钟后评估步态,安全可行
  • 21例无副作用,1例暂时头痛,3例头晕持续不足5分钟
  • 76%(19例)据此避免侵入性检查,可作疑似引流不足的一线无创诊断

核心结论

  • 按压试验安全、有效,能提供快速临床反馈,常可避免更具侵入性和昂贵的检查(本研究中为76%)。
  • 在疑似引流不足时,至少对正常压力脑积水患者,该无创抽吸试验应被视为侵入性诊断之前的一线诊断方法。
  • 并非所有冲洗储液器都适合进行该按压试验。

研究设计与样本

  • 前瞻性单中心研究,纳入25例已行分流术(Sprung-Reservoir和proGAV 2.0)且疑似引流不足的正常压力脑积水患者。
  • 通过按压储液泵100次从脑室抽吸约20 ml脑脊液,10分钟后行步态检查评估即时效应。
  • 使用患者和/或照护者填写的观察表评估一周内变化,并根据结果和后续临床决策确定避免侵入性检查的程度。

主要发现

  • 试验在所有患者中可行,21例无副作用或不适,1例出现暂时头痛,3例报告头晕持续不足5分钟。
  • 10分钟后11例改善,其中8例立即下调分流阀;其余17例发放观察表:6例无改善,7例暂时改善,4例持续改善。
  • 暂时改善者建议下调阀门,持续改善者建议仅在新症状出现时复诊,无改善者继续随访并可能接受侵入性检查。

关键数值与推荐

  • 按压储液泵100次抽吸约20 ml脑脊液,10分钟后评估步态。
  • 10分钟后11例改善,其中8例立即下调分流阀。
  • 观察表随访:6例无改善,7例暂时改善,4例持续改善。
  • 按压试验使19例(76%)避免侵入性检查。

临床怎么用

  • 对疑似引流不足的正常压力脑积水患者,可首先尝试储液泵按压试验作为无创诊断手段。
  • 按压后10分钟评估步态,并结合一周观察表监测延迟效应,以指导阀门调整或进一步检查。
  • 需确认所用冲洗储液器适合该按压试验,并非所有储液器均适用。

局限性

  • 单中心、小样本(25例)前瞻性研究,结果需更大样本验证。
  • 并非所有冲洗储液器都适合该按压试验。
  • 原文未报告对照设计、盲法及长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Suboptimal improvement or secondary deterioration is frequently observed in patients with shunted normal pressure hydrocephalus (NPH). The non-invasive tap test ("pumping-test") performed via the flushing reservoir of shunts may represent an alternative to invasive diagnostic procedures for detecting underdrainage. The aim of this study was to demonstrate its efficacy and potential to reduce the need for invasive diagnostic tests. METHODS: A prospective study was conducted on 25 NPH patients who had been shunted with a "Sprung-Reservoir" and a proGAV 2.0 and in whom underdrainage was suspected. By performing 100 pumps, approximately 20 ml of cerebrospinal fluid (CSF) was withdrawn from the ventricles. Immediate effects were assessed through gait examinations after 10 min, and changes over one week were evaluated using observation sheets completed by patients and/or caregivers. Based on the results and subsequent clinical decisions, the extent to which invasive tests could be avoided was determined. RESULTS: The test was feasible in all patients. It was well tolerated, with no side effects or discomfort in 21 patients. Temporary headaches occurred in 1 patient, and dizziness lasting less than 5 min was reported in 3 patients. Improvement after 10 min was observed in 11 patients; in 8 of these cases, the shunt valve was immediately downregulated. The remaining 17 patients were provided with observation sheets: 6 showed no improvement, 7 reported temporary improvement, and 4 experienced sustained improvement. Patients with temporary improvement were offered valve downregulation, while those with sustained improvement were advised to return only if new symptoms developed. Patients with no improvement were put to further follow-up and possibly offered invasive tests for further clarification. Consequently, the pumping test enabled avoidance of invasive testing in 19 cases (76%). CONCLUSION: The pumping test proved to be safe, effective, and capable of providing rapid clinical feedback. The additional use of observation sheets supports the monitoring of delayed effects. More invasive and costly tests can often be avoided-76% in this study. This non-invasive tap test should be considered a first-line diagnostic procedure in cases of suspected underdrainage, at least in NPH patients, before pursuing invasive diagnostics. However, not all flushing reservoirs are suitable for this "pumping test."

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Kehler U. PUMP study: reservoir pumping in suspected underdrained shunted patients with normal pressure hydrocephalus - a prospective single-center study. Acta Neurochir (Wien). 2025. PMID: 41429939. doi:10.1007/s00701-025-06753-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。